Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Seattle Genetics Inc

+ Add to Watchlist

SGEN:US

43.2300 USD 0.5300 1.21%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Seattle Genetics Inc (SGEN)

Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.

Contact Information

Seattle Genetics Inc

21823 30th Drive SE
Bothell, WA 98021
United States
Phone: 1-425-527-4000
Fax: 1-425-527-4001

Key Executives for Seattle Genetics Inc (SGEN)

Clay B SiegallChairman/Pres/CEO/Co-FounderTodd E SimpsonChief Financial Officer
Eric L DobmeierCOO/SecretaryJean I LiuExec VP:Legal Affairs/Gen Counsel/Secy
Jonathan DrachmanExec VP:Research & DevVaughn B HimesExec VP:Technical Ops
Chris BoernerExec VP:CommercialPeggy PinkstonInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil